n Southern African Journal of HIV Medicine - Advocating access : from the editor




While neighbouring Botswana and other SADC countries and states have been solicited with offers of free or highly reduced-price antiretroviral treatments that will bring the cost of HAART to around US$ 1 000 for a year of therapy per patient, South Africa continues to face tough marketeering by the same drug manufacturers, who see the country as a lucrative market with virtually unlimited need for their products.


Article metrics loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error